-transparent.png){kind=logo}
The pharmacological profile of the new anticonvulsant etazepine (5,6-dihydro-5-methyl-11H-11-ethoxy-dibenzo[b,e]azepin-6-one) was investigated. It protected mice and rats from a wide variety of convulsant agents (maximal electroshock, pentetrazol (metrazole), bicuculline, strychnine, 3-mercaptopropionic acid, nicotine, cefazoline and kainic acid) at doses about 16-45 times lower than those exerting neurotoxic effects (depending on the test used). The anticonvulsant effect of etazepine was long-acting (more than 24 h) and did not seem to develop tolerance. Moreover, etazepine did not prolong thiopental-induced sleeping time. Based on pharmacological studies etazepine seems to exert its anticonvulsant effects by activating the GABAergic system.
F Borsini, and
G Volterra, and
C Cutrufo, and
M Furio, and
A Meli
January 1984,
Arzneimittel-Forschung,
F Borsini, and
G Volterra, and
C Cutrufo, and
M Furio, and
A Meli
January 1980,
Arzneimittel-Forschung,
F Borsini, and
G Volterra, and
C Cutrufo, and
M Furio, and
A Meli
January 1983,
Arzneimittel-Forschung,
F Borsini, and
G Volterra, and
C Cutrufo, and
M Furio, and
A Meli
January 1986,
Bollettino chimico farmaceutico,
F Borsini, and
G Volterra, and
C Cutrufo, and
M Furio, and
A Meli
January 1987,
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
F Borsini, and
G Volterra, and
C Cutrufo, and
M Furio, and
A Meli
June 1992,
Arzneimittel-Forschung,
F Borsini, and
G Volterra, and
C Cutrufo, and
M Furio, and
A Meli
January 1983,
Arzneimittel-Forschung,
F Borsini, and
G Volterra, and
C Cutrufo, and
M Furio, and
A Meli
July 2001,
Epilepsia,
F Borsini, and
G Volterra, and
C Cutrufo, and
M Furio, and
A Meli
December 1983,
Epilepsia,
F Borsini, and
G Volterra, and
C Cutrufo, and
M Furio, and
A Meli
October 1994,
Fortschritte der Neurologie-Psychiatrie,
